The cornerstone of treatment of aBC constitutes of endocrine therapy (ET):including aromatase inhibitors (such as letrozole, anastrozole, and exemestane),selective estrogen receptor (ER) modulators (such as tamoxifen), and ERdown-regulators (such as fulvestrant). This evidence concerns the gene CYP19A1 and aneurysmal bone cyst.